Posttraumatic stress disorder (PTSD) is classified as an anxiety disorder and the characteristic symptoms (re-experiencing, avoidance as well as numbing of general responsiveness and hyperarousal) of this disorder develop in response to a traumatic event. The disorder is characterised by hypothalamic-pituitary-adrenal (HPA) axis abnormalities linked with changes in cortisol moreover, the hippocampus and cortex also play a role in the neurobiology. With regard to the neurochemistry of this disorder it is known that gamma amino butyric acid (GABA) is involved however, the precise role of GABA in PTSD and how stress changes GABA concentrations in the brain are still not fully understood. Another aspect regarding PTSD that has not been clearly defined is the treatment of PTSD. Classic anxiolytics such as diazepam is expected to relieve the anxiety linked with PTSD. Studies with this group of drugs have however not produced the concrete evidence needed to establish it as a treatment of choice for PTSD and subsequently other classes of drugs have been investigated as possible treatment options for PTSD. Among these is lamotrigine, which in a clinical study was found to be effective in alleviating symptoms of PTSD. Moreover, a possible pharmacokinetic-pharmacodynamic relationship for each of these drugs has also not been elucidated. In order to elude on some of these uncertainties, an animal model of PTSD, time dependent sensitisation (TDS), was used. GABA levels in the rat hippocampus and frontal cortex were determined at two different time intervals following the TDS procedure (1 day and 7 days post re-stress). High performance liquid chromatography (HPLC) with electrochemical (EC) detection was used to determine gamma amino butyric acid (GABA) concentrations. To investigate the possible anxiolytic effects of diazepam and lamotrigine in this model, as well as a possible pharmacokinetic-pharmacodynamic relationship for each drug, pharmacokinetic profiles for both drugs were established in order to find the times of peak and trough levels of each drug. Blood samples were collected at different time intervals after drug administration either from the tail vein of rats (lamotrigine) or directly from the heart (diazepam). Subsequently, drug concentrations at each time interval were determined by means of HPLC with ultraviolet (UV) detection. The behaviour of rats was analysed using the elevated plus-maze (EPM) at peak or trough concentrations of the drugs and this was performed after either acute administration of the drug, or after a 14 day chronic treatment regime. GABA levels in the hippocampus were not found to change statistically significantly in response to stress at either 1 day or 7 days post re-stress. In the frontal cortex, however, GABA levels increased in response to stress at 1 day post re-stress, with a statistically insignificant, but strong trend towards an increase, at 7 days post re-stress. With regard to the pharmacokinetic profiles, the peak concentration of diazepam was found to occur at 60 minutes, with lamotrigine's peak at 120 minutes. The behavioural studies indicated that acute treatment with diazepam 3 mg/kg resulted in a statistically significant increase in both ratio open arm entries and ratio time spent in the open arms at peak level of the drug. After acute treatment with diazepam 3 mg/kg a statistically significant decrease in ratio time spent in open arms was also found when the ratio time spent in open arms at peak level of the drug and the ratio time spent in open arms at trough level of the drug was compared. In response to chronic treatment with diazepam 3 mg/kg for 14 days, test animals exhibited an increase in the ratio open arm entries at trough level of the drug, with a statistically insignificant yet definite trend towards an increase at peak level. Acute treatment with lamotrigine 10 mg/kg resulted in no statistically significant change in EPM parameters. In response to chronic treatment, however, a statistically significant increase was found in ratio time spent in open arms at peak level of the drug, with a statistically insignificant trend towards an increase at trough level. From the results of this study, we may therefore conclude that GABA-levels in the brain are definitely affected, but in different ways, following TDS-stress. A pharmacokinetic-pharmacodynamic relationship between the drugs' levels and aversive behaviour could also be established. Furthermore it appears that more sustained anxiolytic effects are evident following chronic treatment with both drugs than with acute administration of these drugs. / Thesis (M.Sc. (Pharmacology))--North-West University, Potchefstroom Campus, 2006

O objetivo do presente estudo foi avaliar se ratos tratados com chá de ayahuasca apresentam i) alterações comportamentais no campo aberto e labirinto em cruz elevado (LCE); ii) alterações na expressão do transportador de glutamato (EAAC1) no córtex pré-frontal (CPF) e no hilus do giro denteado do hipocampo (HDG). Doze grupos de ratos Wistar machos (250g, n=10/cada) foram usados. Eles receberam 2 or 4ml/Kg de chá de ayahuasca ou água: dose única (agudo), 3 vezes/dia por 3 dias alternados (subcrônico) e 1 vez/dia por 15 dias (crônico). Trinta minutos após a última ingestão os animais foram submetidos aos testes comportamentais. Vinte e quatro horas após eles foram anestesiados, perfundidos e seus encéfalos seccionados (40-m) no hipocampo e CPF para os experimentos de imunoistoquimica para EAAC1. Comparações estatísticas entre cada grupo tratado com ayahuasca e seu respectivo controle foram feitas utilizando o teste t de Student e consideradas significantes quando p0,05. Apenas a ingestão subcrônica de ayahuasca induziu redução significante na atividade locomotora (27%) no campo aberto. No LCE nenhum dos tratamentos com ayahuasca induziu alterações significantes em ambos numero de entradas e tempo de permanência nos braços abertos. A ingestão subcrônica ou crônica de chá de ayahuasca induziu aumento significante na expressão de EAAC1 no HGD (20-67%). Em contraste, no CPF a expressão de EAAC1 foi significantemente reduzida em ratos tratados com 2 ou 4ml/Kg subcronicamente ou 4ml/Kg cronicamente (17-25%). A ingestão aguda de 2ml/Kg induziu discreto aumento na expressão de EAAC1 (16%). Estes resultados sugerem que i) Ayahuasca induz alterações nas atividades locomotora e exploratória de forma dependente da dose e frequência de ingestão; ii) Ayahuasca não tem efeito no nível de ansiedade; iii) A ingestão aguda, subcrônica e subcrônica de ayahuasca disparam distintos mecanismos no hipocampo e CPF envolvendo a modulação da neurotransmissão glutamatérgica. / This work aimed at investigating whether rats treated with Ayahuasca beverage show i) behavioral alterations in the open field and elevated plus maze (EPM); ii) alterations in the expression of glutamate transporter (EAAC1) in the prefrontal cortex (PFC) and in the hilus of dentate gyrus of the hippocampus (HDG). Twelve groups of male Wistar rats (250g, n=10/each) were used. They received 2ml/Kg or 4ml/Kg of ayauhasca beverage or water: only once (acute), 3 times/day for 3 days (sub-chronic) or once/day for 15 days (chronic). Thirty minutes after the last ingestion the animals were submitted to behavioural tests. After 24 hours they were anaesthetized, perfused and their brains sectioned (40-m) in the hippocampus and PFC for immunohistochemistry (IH) detection of EAAC1. Comparisons between ayahuasca and control groups used Student t test. Significance was set at p0.05. Only sub-chronic ingestion of Ayahuasca induced a decrease in locomotor (27%) activit in the open field. On the EPM all treatments with Ayahuasca induced no significant increase in both number of entries and time spent in the open arms. The sub-chronic and chronic treatments with Ayahuasca induced a significant increase in EAAC1 expression in the HDG (20-67%). In contrast, in the PFC the expression of EAAC1 was significantly decreased in rats treated with 2 or 4ml/Kg sub-chronically or 4ml/Kg chronically (17-25%). Acute ingestion of 2ml/Kg induced a smaller increase in EAAC1-IC (16%). These results suggest that i) Ayahuasca changes the locomotor and exploratory activities in a way depending the dose and frequency of ingestion; ii) Ayahuasca does not have effect on the level of anxiety; iii) Acute, sub-chronic or chronic ingestion of Ayahuasca beverage trigger distinct mechanisms in the PFC and hippocampus involving the modulation of glutamate neurotransmission.

Thesis (M.Sc. (Pharmacology))--North-West University, Potchefstroom Campus, 2006.

Posttraumatic stress disorder (PTSD) is an anxiety disorder that may result from an exposure to a severely traumatic life-event. It is characterised by a delayed onset of psychological and physical symptoms including re-experiencing the event, avoidance of reminders associated with the trauma, increased autonomic arousal and distinct memory deficits. This disorder is also characterised by a maladaptive hypothalamic-pituitary-adrenal (HPA)-axis response and altered monoamine concentrations in the hippocampus and pre-frontal cortex. The Time Dependent Sensitization (TDS) model is a putative animal model of PTSD that is based on the concept of repeated trauma, using three acute stressors (TS) of intense severity followed by a mild situational reminder (RS) on day 7 subsequent to the acute stressors. The aims of this study were to determine if the Triple Stressor (TS) induces stress and if the situational reminder (RS) is necessary for the maintenance of the stress response over time and whether these two stress responses are qualitatively and quantitively different. This was done to further validate the TDS model and to characterize the development and progression of the stress-related pathology of PTSD. Methods used were High Performance Liquid Chromatography (HPLC) with electrochemical detection (biochemical correlates) for quantifying the monoamines dopamine (DA), noradrenaline (NA) and serotonin (5-HT) concentrations in the hippocampus and pre-frontal cortex (PFC); radio immuno assay (RIA) for the determination of plasma corticosterone concentrations (neuroendocrine parameter) and the use of the Elevated Plus Maze (EPM) to detect anxiety-like behaviour (behavioural analyses). The study was subdivided into an Acute and Re-Stress study (n = 10). In the Acute Study rats were exposed to TS as the only stressor. Group 1 was sacrificed immediately after TS, Group 2 was sacrificed 3 days post TS and Group 3 on day 7 post TS. In the Re-Stress Study both TS and RS were used as stressors. Group 4 was sacrificed immediately after the situational reminder, Group 5 was sacrificed 3 days post RS and Group 6 on day 7 post RS. A group of unstressed rats were used as Control. The results of this study found corticosterone concentrations elevated immediately after the TS (p<0.05). Exposure to the RS resulted in a profound hypocortisolism (p<0.05). These results indicate a possible disturbance in the regulation of the HPA-axis, which manifests as an enhanced negative feed-back upon re-introduction of the stressful situation. Changes in MA concentrations were evident. Although no definite fixed trend is apparent in this study, it is evident that the TDS model does induce monoamine dysregulation. Hippocampal NA. DA and 5-HT concentrations were noted to be elevated on day 7 post TS (p<0.05). On day 7 post RS only hippocampal 5HT was decreased significantly (p<0.05). Behavioural analyses indicate that stress related anxiety was not sustained after the TS but 7 days after the exposure to the RS rats were most anxious (p<0.05). The results confirm that the TDS model does induce PTSD-like symptoms in rats and that the situational reminder (RS) is necessary for the maintenance of the stress response. This model may be useful in the investigation of future experimental pharmacological interventions in the management of PTSD. / Thesis (M.Sc. (Pharmacology))--North-West University, Potchefstroom Campus, 2005.

Posttraumatic stress disorder (PTSD) is an anxiety disorder that may result from an exposure to a severely traumatic life-event. It is characterised by a delayed onset of psychological and physical symptoms including re-experiencing the event, avoidance of reminders associated with the trauma, increased autonomic arousal and distinct memory deficits. This disorder is also characterised by a maladaptive hypothalamic-pituitary-adrenal (HPA)-axis response and altered monoamine concentrations in the hippocampus and pre-frontal cortex. The Time Dependent Sensitization (TDS) model is a putative animal model of PTSD that is based on the concept of repeated trauma, using three acute stressors (TS) of intense severity followed by a mild situational reminder (RS) on day 7 subsequent to the acute stressors. The aims of this study were to determine if the Triple Stressor (TS) induces stress and if the situational reminder (RS) is necessary for the maintenance of the stress response over time and whether these two stress responses are qualitatively and quantitively different. This was done to further validate the TDS model and to characterize the development and progression of the stress-related pathology of PTSD. Methods used were High Performance Liquid Chromatography (HPLC) with electrochemical detection (biochemical correlates) for quantifying the monoamines dopamine (DA), noradrenaline (NA) and serotonin (5-HT) concentrations in the hippocampus and pre-frontal cortex (PFC); radio immuno assay (RIA) for the determination of plasma corticosterone concentrations (neuroendocrine parameter) and the use of the Elevated Plus Maze (EPM) to detect anxiety-like behaviour (behavioural analyses). The study was subdivided into an Acute and Re-Stress study (n = 10). In the Acute Study rats were exposed to TS as the only stressor. Group 1 was sacrificed immediately after TS, Group 2 was sacrificed 3 days post TS and Group 3 on day 7 post TS. In the Re-Stress Study both TS and RS were used as stressors. Group 4 was sacrificed immediately after the situational reminder, Group 5 was sacrificed 3 days post RS and Group 6 on day 7 post RS. A group of unstressed rats were used as Control. The results of this study found corticosterone concentrations elevated immediately after the TS (p<0.05). Exposure to the RS resulted in a profound hypocortisolism (p<0.05). These results indicate a possible disturbance in the regulation of the HPA-axis, which manifests as an enhanced negative feed-back upon re-introduction of the stressful situation. Changes in MA concentrations were evident. Although no definite fixed trend is apparent in this study, it is evident that the TDS model does induce monoamine dysregulation. Hippocampal NA. DA and 5-HT concentrations were noted to be elevated on day 7 post TS (p<0.05). On day 7 post RS only hippocampal 5HT was decreased significantly (p<0.05). Behavioural analyses indicate that stress related anxiety was not sustained after the TS but 7 days after the exposure to the RS rats were most anxious (p<0.05). The results confirm that the TDS model does induce PTSD-like symptoms in rats and that the situational reminder (RS) is necessary for the maintenance of the stress response. This model may be useful in the investigation of future experimental pharmacological interventions in the management of PTSD. / Thesis (M.Sc. (Pharmacology))--North-West University, Potchefstroom Campus, 2005.

Posttraumatic stress disorder (PTSD) is classified as an anxiety disorder and the characteristic symptoms (re-experiencing, avoidance as well as numbing of general responsiveness and hyperarousal) of this disorder develop in response to a traumatic event. The disorder is characterised by hypothalamic-pituitary-adrenal (HPA) axis abnormalities linked with changes in cortisol moreover, the hippocampus and cortex also play a role in the neurobiology. With regard to the neurochemistry of this disorder it is known that gamma amino butyric acid (GABA) is involved however, the precise role of GABA in PTSD and how stress changes GABA concentrations in the brain are still not fully understood. Another aspect regarding PTSD that has not been clearly defined is the treatment of PTSD. Classic anxiolytics such as diazepam is expected to relieve the anxiety linked with PTSD. Studies with this group of drugs have however not produced the concrete evidence needed to establish it as a treatment of choice for PTSD and subsequently other classes of drugs have been investigated as possible treatment options for PTSD. Among these is lamotrigine, which in a clinical study was found to be effective in alleviating symptoms of PTSD. Moreover, a possible pharmacokinetic-pharmacodynamic relationship for each of these drugs has also not been elucidated. In order to elude on some of these uncertainties, an animal model of PTSD, time dependent sensitisation (TDS), was used. GABA levels in the rat hippocampus and frontal cortex were determined at two different time intervals following the TDS procedure (1 day and 7 days post re-stress). High performance liquid chromatography (HPLC) with electrochemical (EC) detection was used to determine gamma amino butyric acid (GABA) concentrations. To investigate the possible anxiolytic effects of diazepam and lamotrigine in this model, as well as a possible pharmacokinetic-pharmacodynamic relationship for each drug, pharmacokinetic profiles for both drugs were established in order to find the times of peak and trough levels of each drug. Blood samples were collected at different time intervals after drug administration either from the tail vein of rats (lamotrigine) or directly from the heart (diazepam). Subsequently, drug concentrations at each time interval were determined by means of HPLC with ultraviolet (UV) detection. The behaviour of rats was analysed using the elevated plus-maze (EPM) at peak or trough concentrations of the drugs and this was performed after either acute administration of the drug, or after a 14 day chronic treatment regime. GABA levels in the hippocampus were not found to change statistically significantly in response to stress at either 1 day or 7 days post re-stress. In the frontal cortex, however, GABA levels increased in response to stress at 1 day post re-stress, with a statistically insignificant, but strong trend towards an increase, at 7 days post re-stress. With regard to the pharmacokinetic profiles, the peak concentration of diazepam was found to occur at 60 minutes, with lamotrigine's peak at 120 minutes. The behavioural studies indicated that acute treatment with diazepam 3 mg/kg resulted in a statistically significant increase in both ratio open arm entries and ratio time spent in the open arms at peak level of the drug. After acute treatment with diazepam 3 mg/kg a statistically significant decrease in ratio time spent in open arms was also found when the ratio time spent in open arms at peak level of the drug and the ratio time spent in open arms at trough level of the drug was compared. In response to chronic treatment with diazepam 3 mg/kg for 14 days, test animals exhibited an increase in the ratio open arm entries at trough level of the drug, with a statistically insignificant yet definite trend towards an increase at peak level. Acute treatment with lamotrigine 10 mg/kg resulted in no statistically significant change in EPM parameters. In response to chronic treatment, however, a statistically significant increase was found in ratio time spent in open arms at peak level of the drug, with a statistically insignificant trend towards an increase at trough level. From the results of this study, we may therefore conclude that GABA-levels in the brain are definitely affected, but in different ways, following TDS-stress. A pharmacokinetic-pharmacodynamic relationship between the drugs' levels and aversive behaviour could also be established. Furthermore it appears that more sustained anxiolytic effects are evident following chronic treatment with both drugs than with acute administration of these drugs. / Thesis (M.Sc. (Pharmacology))--North-West University, Potchefstroom Campus, 2006

O objetivo do presente estudo foi avaliar se ratos tratados com chá de ayahuasca apresentam i) alterações comportamentais no campo aberto e labirinto em cruz elevado (LCE); ii) alterações na expressão do transportador de glutamato (EAAC1) no córtex pré-frontal (CPF) e no hilus do giro denteado do hipocampo (HDG). Doze grupos de ratos Wistar machos (250g, n=10/cada) foram usados. Eles receberam 2 or 4ml/Kg de chá de ayahuasca ou água: dose única (agudo), 3 vezes/dia por 3 dias alternados (subcrônico) e 1 vez/dia por 15 dias (crônico). Trinta minutos após a última ingestão os animais foram submetidos aos testes comportamentais. Vinte e quatro horas após eles foram anestesiados, perfundidos e seus encéfalos seccionados (40-m) no hipocampo e CPF para os experimentos de imunoistoquimica para EAAC1. Comparações estatísticas entre cada grupo tratado com ayahuasca e seu respectivo controle foram feitas utilizando o teste t de Student e consideradas significantes quando p0,05. Apenas a ingestão subcrônica de ayahuasca induziu redução significante na atividade locomotora (27%) no campo aberto. No LCE nenhum dos tratamentos com ayahuasca induziu alterações significantes em ambos numero de entradas e tempo de permanência nos braços abertos. A ingestão subcrônica ou crônica de chá de ayahuasca induziu aumento significante na expressão de EAAC1 no HGD (20-67%). Em contraste, no CPF a expressão de EAAC1 foi significantemente reduzida em ratos tratados com 2 ou 4ml/Kg subcronicamente ou 4ml/Kg cronicamente (17-25%). A ingestão aguda de 2ml/Kg induziu discreto aumento na expressão de EAAC1 (16%). Estes resultados sugerem que i) Ayahuasca induz alterações nas atividades locomotora e exploratória de forma dependente da dose e frequência de ingestão; ii) Ayahuasca não tem efeito no nível de ansiedade; iii) A ingestão aguda, subcrônica e subcrônica de ayahuasca disparam distintos mecanismos no hipocampo e CPF envolvendo a modulação da neurotransmissão glutamatérgica. / This work aimed at investigating whether rats treated with Ayahuasca beverage show i) behavioral alterations in the open field and elevated plus maze (EPM); ii) alterations in the expression of glutamate transporter (EAAC1) in the prefrontal cortex (PFC) and in the hilus of dentate gyrus of the hippocampus (HDG). Twelve groups of male Wistar rats (250g, n=10/each) were used. They received 2ml/Kg or 4ml/Kg of ayauhasca beverage or water: only once (acute), 3 times/day for 3 days (sub-chronic) or once/day for 15 days (chronic). Thirty minutes after the last ingestion the animals were submitted to behavioural tests. After 24 hours they were anaesthetized, perfused and their brains sectioned (40-m) in the hippocampus and PFC for immunohistochemistry (IH) detection of EAAC1. Comparisons between ayahuasca and control groups used Student t test. Significance was set at p0.05. Only sub-chronic ingestion of Ayahuasca induced a decrease in locomotor (27%) activit in the open field. On the EPM all treatments with Ayahuasca induced no significant increase in both number of entries and time spent in the open arms. The sub-chronic and chronic treatments with Ayahuasca induced a significant increase in EAAC1 expression in the HDG (20-67%). In contrast, in the PFC the expression of EAAC1 was significantly decreased in rats treated with 2 or 4ml/Kg sub-chronically or 4ml/Kg chronically (17-25%). Acute ingestion of 2ml/Kg induced a smaller increase in EAAC1-IC (16%). These results suggest that i) Ayahuasca changes the locomotor and exploratory activities in a way depending the dose and frequency of ingestion; ii) Ayahuasca does not have effect on the level of anxiety; iii) Acute, sub-chronic or chronic ingestion of Ayahuasca beverage trigger distinct mechanisms in the PFC and hippocampus involving the modulation of glutamate neurotransmission.

Made available in DSpace on 2016-06-02T19:22:55Z (GMT). No. of bitstreams: 1 3795.pdf: 1250266 bytes, checksum: 92066a2c1ad5d8123001121adcd92bc3 (MD5) Previous issue date: 2011-03-02 / Financiadora de Estudos e Projetos / Against of stimuli that are dangerous, animals manifest defense reactions that cause fear and anxiety. These stimuli activate the serotonergic system, which sends projections to structures involved in defense mechanisms such as the septum, hypothalamus, hippocampus, amygdala and periaqueductal gray modulates the behavioral changes that can be characterized as anxiety. Studies have shown that 5-HT3 receptors are part of this modulation. The elevated plus maze (EPM) is a widely used animal model to evaluate the anxiolytic activity of drugs. Currently, it is known that the retest in rodents (rats and mice) increases the avoidance of it, this phenomenon, which refers to "a display of tolerance" (OTT, One Trial Tolerance). The amygdala is a prosencephalic structures that have significant amount of serotonin (5-HT) in this way, recent results from our laboratory have shown that microinjections of ondansetron antagonist 5-HT3 receptors in the amygdala of mice produced anxiolytic-like effect evaluated in LCE. The aim of this study was to evaluate the involvement of receptors 5-HT3 receptors in the amygdala of mice prior experience the elevated plus-maze (EPM). Conventional measures of anxiety (% of entry and time spent in open arms), locomotor activity (frequency in closed arms) and ethological measures related to risk assessment were recorded. The present study demonstrated that intra-amygdala of ondansetron, antagonist of 5-HT3 receptors, produced anxiolytic-like effects in naive mice and mice prior experience the LCE. The injection of ondansetron in only one of the exhibits produced anxiolytic-like effect, which leads us to conclude that the drug produced no change in memory. Both the Trial 1 and in Trial 2, none treatments affected locomotor activity. So while the amygdala is involved in the neurobiology of the defense reactions such as anxiety response, as it refers to the phenomenon it seems OTT not to participate. / Diante de estímulos que representam perigo os animais manifestam reações de defesa que originam o medo e a ansiedade. Estes estímulos ativam o sistema serotonérgico, o qual emite projeções para estruturas envolvidas nos mecanismos de defesa tais como, septo, hipotálamo, hipocampo, substância cinzenta periaquedutal e amídala, modulando as alterações comportamentais que podem ser caracterizadas como ansiedade. Estudos têm demonstrado que os receptores 5-HT3 fazem parte desta modulação. O labirinto em cruz elevado (LCE) é um modelo animal amplamente utilizado para avaliar a atividade ansiolítica de drogas. Atualmente, sabe-se que o reteste em roedores (ratos e camundongos) aumenta a evitação do mesmo, fenômeno este, que se refere à tolerância de uma exposição (OTT, do inglês One Trial Tolerance). A amídala é uma das estruturas prosencefálicas que apresentam quantidade relevante de serotonina (5-HT), dessa forma, resultados recentes do nosso laboratório demonstram que microinjeções de ondansetron, antagonista dos receptores 5- HT3, na amídala de camundongos, produziu efeito ansiolítico avaliado no LCE. O objetivo deste estudo foi avaliar o envolvimento dos receptores 5-HT3 na amídala de camundongos reexpostos ao labirinto em cruz elevado (LCE). Medidas convencionais de ansiedade (% de entrada e de tempo gasto nos braços abertos), atividade locomotora (freqüência de entrada nos braços fechados) e medidas etológicas relacionadas à avaliação de risco foram registradas. O presente estudo demonstrou que a injeção intra-amídala de ondansetron, antagonista de receptores 5-HT3, produziu efeito ansiolítico tanto em camundongos ingênuos quanto em camundongos reexpostos ao LCE. A injeção de ondansetron em apenas uma das exposições produziu efeito ansiolítico, o que nos leva a concluir que a droga não produziu alteração da memória. Tanto na exposição 1 como na reexposição, nenhum dos tratamentos afetou a atividade locomotora. Portanto, embora a amídala esteja envolvida na neurobiologia das reações de defesa, tais como a resposta de ansiedade, no que se que refere ao fenômeno OTT ela parece não participar.